Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab … TJ Price, JE Hardingham, CK Lee, A Weickhardt, AR Townsend, JW Wrin, ... Journal of Clinical Oncology 29 (19), 2675-2682, 2011 | 262 | 2011 |
Pharmacological blockade of aquaporin-1 water channel by AqB013 restricts migration and invasiveness of colon cancer cells and prevents endothelial tube formation in vitro HS Dorward, A Du, MA Bruhn, J Wrin, JV Pei, A Evdokiou, TJ Price, ... Journal of Experimental & Clinical Cancer Research 35, 1-9, 2016 | 81 | 2016 |
Dissecting the biology of menstrual cycle-associated breast cancer risk V Atashgaran, J Wrin, SC Barry, P Dasari, WV Ingman Frontiers in oncology 6, 267, 2016 | 68 | 2016 |
Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab TJ Price, JE Hardingham, CK Lee, AR Townsend, JW Wrin, K Wilson, ... Cancer medicine 2 (3), 277-285, 2013 | 42 | 2013 |
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in … TJ Price, MA Bruhn, CK Lee, JE Hardingham, AR Townsend, KP Mann, ... British journal of cancer 112 (6), 963-970, 2015 | 40 | 2015 |
Nanostructured polystyrene well plates allow unbiased high-throughput characterization of circulating tumor cells Y Wan, M Winter, B Delalat, JE Hardingham, PK Grover, J Wrin, ... ACS applied materials & interfaces 6 (23), 20828-20836, 2014 | 34 | 2014 |
Monoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSF RF Halenbeck, KE Koths, JW Wrin US Patent 5,491,065, 1996 | 21 | 1996 |
High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients … SS Kumar, Y Tomita, J Wrin, M Bruhn, A Swalling, M Mohammed, TJ Price, ... Clinical and Translational Oncology 19, 718-726, 2017 | 18 | 2017 |
Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age SM Bernhardt, P Dasari, J Wrin, W Raymond, S Edwards, D Walsh, ... Breast Cancer Research 22, 1-10, 2020 | 15 | 2020 |
Identification of a cell surface protein with a role in stimulating human keratinocyte proliferation, expressed during development and carcinogenesis P Kaur, S Paton, J Furze, J Wrin, S Olsen, J Danks, J Scurry Journal of investigative dermatology 109 (2), 194-199, 1997 | 12 | 1997 |
Building performance dashboards and balanced scorecards with SQL server reporting services C Price, A Jorgensen, D Knight John Wiley & Sons, 2013 | 10 | 2013 |
BRAF V600E Mutation Detection Using High Resolution Probe Melting Analysis, Polymerase Chain Reaction. Hernandez-Rodriguez P (Eds.). ISBN: 978-953-51-0612-8 JE Hardingham, A Chua, JW Wrin, A Shivasami, I Kanter, NC Tebbutt, ... Tech, Retrieved March, 2015 | 5 | 2015 |
BRAF V600E Mutation Detection Using High Resolution Probe Melting Analysis JE Hardingham, A Chua, JW Wrin, A Shivasami, I Kanter, NC Tebbutt, ... Polymerase Chain Reaction, 2012 | 1 | 2012 |
The Effect Of Age And Menstrual Cycling On Gene Expression Profiling Tests SM Bernhardt, P Dasari, J Wrin, W Raymond, S Edwards, D Walsh, ... The Breast 68, 240-241, 2023 | | 2023 |
Development and Evaluation of Mouse Monoclonal Antibodies Against Human C1q JW Wrin | | 2022 |
The effect of aquaporin-5 knockdown on HT29 colon cancer cell proliferation and migration Y Tomita, H Dorward, J Wrin, RJ Vary, ML De Ieso, AJ Yool, J Price, ... ANNALS OF ONCOLOGY 26, 4-4, 2015 | | 2015 |
14P The effect of aquaporin-5 knockdown on HT29 colon cancer cell proliferation and migration Y Tomita, H Dorward, J Wrin, RJ Vary, ML De Ieso, AJ Yool, TJ Price, ... Annals of Oncology 26, ix1, 2015 | | 2015 |
Basic science Y Tomita, H Dorward, J Wrin, RJ Vary, ML De Ieso, AJ Yool, TJ Price, ... | | 2015 |
Pten and Advanced Colorectal Cancer (CRC): Analysis from the Phase III Agitg Max Trial of Capecitabine Alone or in Combination with Bevacizumab+/-Mitomycin C T Price, J Hardingham, C Lee, A Townsend, J Wrin, K Wilson, ... Annals of Oncology 23, ix182, 2012 | | 2012 |
IMPACT OF KRAS AND BRAF GENE MUTATION STATUS ON OUTCOMES FROM THE PHASE III AGITG MAX TRIAL OF CAPECITABINE (C) ALONE OR IN COMBINATION WITH BEVACIZUMAB (B)+/-MITOMYCIN C (M … TJ Price, J Hardingham, C Lee, A Weickhardt, A Townsend, JW Wrin, ... ANNALS OF ONCOLOGY 21, 198-198, 2010 | | 2010 |